High Dose Infliximab in the Treatment of Refractory Uveitis : Does Dose Matter?

High Dose Infliximab in the Treatment of Refractory Uveitis : Does Dose Matter?

Background. Infliximab (INF) has been shown to be beneficial in treating refractory uveitis, however, no data exist on optimal dosing and the efficacy of higher dosing. Objectives. To compare the efficacy of low-dose (LD) (

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:ISRN rheumatology 2012, Vol.2012 (2012), p.1-8
Hauptverfasser: Sukumaran, Sukesh, Marzan, Katherine, Shaham, Bracha, Reiff, Andreas O.
Format: Artikel
Sprache:eng
Schlagworte:
Arthritis
Children & youth
Clinical Study
Disease
Failure
Hospitals
Pathogenesis
Pediatrics
Rheumatic diseases
Rheumatology
Rodents
Vascular endothelial growth factor
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Background. Infliximab (INF) has been shown to be beneficial in treating refractory uveitis, however, no data exist on optimal dosing and the efficacy of higher dosing. Objectives. To compare the efficacy of low-dose (LD) (
ISSN:2090-5467
2090-5475
2090-5475
DOI:10.5402/2012/765380